Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03488381 · ClinicalTrials.gov registry record · NA
Effects of Soccer Heading on Ocular-motor Function and Blood Biomarker
A NA study of Trauma, Head, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT03488381: Completed NA study of Trauma, Head, sponsored by Indiana University.
NCT03488381 is a NA study of Trauma, Head that has completed, run by Indiana University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03488381, a NA study of Trauma, Head, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Repetitive head impacts in sports and military may cause deleterious effects in the nervous system. Investigators' previous works in football players have shown promising results in prediction of concussion and prevention of long-term defect using eye-movement paradigm (ocular-motor system) and blood biomarker. However, acute head impact effects on aforementioned parameters remain unknown. Thus, to answer a critical research question that whether or not ocular-motor system and brain-derived blood biomarker may be acutely altered following 10 successions of controlled soccer heading. To answer the question, investigators hypothesized that acute bout of soccer heading will not elicit noticeable change in subject's symptoms but to induce a transient defect in the ocular-motor system and increase plasma expression of brain-derived biomarker.
Primary Outcome
Outcome measure will be the slope of increased (worsened) levels of blood biomarkers compared to the baseline and control group
Conditions Studied
Interventions
- DEVICE Soccer Heading
Study Locations (1)
Indiana
- Indiana University - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-04-09 |
| Phase | NA |
What the finished NCT03488381 record still lists
NCT03488381 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Trauma, Head appearing as the primary indexed condition, and to 1 intervention - of which Soccer Heading is the first listed.
NCT03488381 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03488381 about?
NCT03488381 is a clinical study titled "Effects of Soccer Heading on Ocular-motor Function and Blood Biomarker". Repetitive head impacts in sports and military may cause deleterious effects in the nervous system. Investigators' previous works in football players have shown promising results in prediction of concussion and prevention of long-term defect using eye-movement paradigm (ocular-motor system) and bloo...
What is the current status of trial NCT03488381?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2017-08-01. Estimated completion is 2019-04-09.
What conditions does trial NCT03488381 study?
This clinical trial studies the following conditions: Trauma, Head.
What interventions are being tested in trial NCT03488381?
The interventions under investigation include: Soccer Heading (DEVICE).
Who is sponsoring clinical trial NCT03488381?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03488381 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03488381's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI